Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus as Neo-adjuvant Therapy in Chondrosarcoma
NCT02008019Phase 2Suspended
- Sponsor
- Centre Léon Bérard
- Start
- Aug 2014
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in chondrosarcoma, sponsored by Centre Léon Bérard. Started Aug 2014; status: suspended.
02
Drugs
everolimus
03
Conditions
chondrosarcoma
Beyond the preview
Go deeper on NCT02008019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008019.